HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antiepileptic monotherapy and combination therapy of simple focal seizures].

Abstract
According to present state of literature complete seizure control can be obtained in about 50% of patients with simple partial seizures. In several studies on previously untreated patients with simple partial seizures most patients became seizure-free with carbamazepine or phenobarbital or phenytoin or primidone or valproic acid used as monotherapy. Previous experience has shown that in patients whose seizures are not completely controlled by monotherapy drug combinations like carbamazepine with phenobarbital or primidone or valproic acid and phenytoin with phenobarbital or primidone or valproic acid should be initiated. Several animal experiments are suggestive for a synergistic effect of different antiepileptic drugs. In a previously published study on carbamazepine monotherapy, 6 out of 9 patients with simple partial seizures became seizure-free or improved markedly by this treatment.
AuthorsW Fröscher, K D Stoll
JournalFortschritte der Neurologie-Psychiatrie (Fortschr Neurol Psychiatr) Vol. 53 Issue 12 Pg. 447-53 (Dec 1985) ISSN: 0720-4299 [Print] Germany
Vernacular TitleAntiepileptische Monotherapie und Kombinationstherapie bei einfachfokalen Anfällen.
PMID3935555 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anticonvulsants
  • Carbamazepine
  • Clonazepam
  • Phenytoin
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (therapeutic use)
  • Carbamazepine (therapeutic use)
  • Child
  • Clonazepam (therapeutic use)
  • Drug Therapy, Combination
  • Electroencephalography
  • Epilepsies, Partial (drug therapy)
  • Epilepsy, Tonic-Clonic (drug therapy)
  • Evoked Potentials (drug effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenytoin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: